Skip to main content

Featured

Daily Markets Update: TSX Hits 4-Month Low, Anthropic IPO Lifts Futures

  CANADIAN MONEY BRIEF Daily Markets Update Thursday, November 19, 2026  |  Wednesday’s closes, plus Thursday’s Asian session and U.S. futures The short version: A commodity rout hit Canada hardest. The S&P/TSX Composite Index lost 737.25 points, or 2.09%, to close at 34,578.05, its lowest finish in more than four months, as gold, copper and oil all fell sharply. On Wall Street, the Dow dropped 561 points and the S&P 500 notched a fifth straight loss, while the Nasdaq edged higher even after Nvidia’s post-earnings pop faded. Thursday opens on a brighter note: U.S. futures are up roughly 1% to 2% after Anthropic priced the largest IPO on record, ahead of its Nasdaq debut. Market Snapshot Index / Asset Level Change S&P/TSX Composite 34,578.05 ▼ -2.09% Dow Jones Industrial Average 50,198.17 ▼ -1.11% S&P 500 7,323.63 ▼ -0.23% Nasdaq Composite 24,429.88 ▲ +0.42% STOXX Europe 600 644.05 ▼ -1.03% Nikkei 225 (Thu.) 59,444.21 ▲ +0.71% Hang Seng (Thu.) 22,841.62 ▼ ...

article

Federal Government Boosts Vaccine Injury Compensation Fund with Additional $36 Million

 

The Canadian federal government has recently allocated an additional $36.4 million to the Vaccine Injury Compensation Fund, a program designed to support individuals who have experienced serious injuries or fatalities related to vaccines since the end of 2020. Here are the key details:

  1. Purpose of the Fund:

    • The program was established shortly after COVID-19 vaccines became available to the public.
    • It provides financial compensation to people who suffered adverse effects due to Health Canada-approved vaccines.
    • The goal is to assist those who were seriously impacted by vaccination.
  2. Funding and Administration:

    • The Liberal government initially earmarked $75 million for the first five years of the program.
    • A private firm called OXARO manages the program and disburses valid claims originating outside of Quebec.
    • To date, OXARO has received $56.2 million from Ottawa and has paid out $11.2 million in compensation.
    • Quebec has its own vaccine injury compensation program, which received $7.75 million when the federal program launched.
  3. Recent Funding Boost:

    • As part of the federal budget, the government allocated an additional $36 million to OXARO and Quebec.
    • This funding covers the next two years of the program.
    • The Public Health Agency of Canada contracted OXARO to ensure an impartial claims process.
  4. Eligibility and Claims:

    • The program covers injuries and deaths associated with vaccines approved for any illness.
    • Eligibility criteria include severe, life-threatening, or life-altering injuries resulting in disability, incapacity, birth defects, or death.
    • The available statistics do not specify which vaccines were involved.
  5. Rare Adverse Reactions:

    • Serious adverse reactions to vaccines are extremely rare (affecting less than one in a million people).
    • Nevertheless, the government recognizes its duty to provide support when such reactions occur.
    • Ottawa has also made COVID-19 vaccination mandatory for travel and federal public service employment.

In summary, the additional funding aims to ensure that those affected by vaccine-related injuries receive appropriate compensation while maintaining an impartial claims process. The program underscores the importance of vaccine safety and accountability in public health efforts. 


Comments